The World Anti-Doping Agency (Wada) has announced that a scientific evaluation will be conducted starting next year to determine if cannabis should no longer be classified as a prohibited substance for athletes.
This decision follows the highly publicized case of Sha’Carri Richardson earlier this year. Richardson, a top contender for the Olympic gold medal in the 100m sprint, was disqualified from competing in Tokyo in June after testing positive for cannabis. She was also required to forfeit the gold medal she had earned at the US Olympic Trials.
Wada revealed the inquiry on Tuesday, stating that it will be conducted by an advisory group associated with the main body. It was clarified that cannabis remains a prohibited substance at present and will remain so through 2022, pending the completion of the review and achieving a consensus on the matter.
“After receiving requests from various stakeholders, the [executive committee] supported the decision of the List Expert Advisory Group to commence a scientific appraisal of cannabis status in 2022,” as stated in a Wada announcement. “Cannabis is currently not allowed during competitions and will remain prohibited in 2022.”
In Richardson’s defense, she cited her use of cannabis to cope with her mother’s passing, arguing that it does not enhance performance. Her case generated significant calls for a reevaluation, including from the US Anti-Doping Agency.
